Minneapolis medical device maker Conventus Orthopaedics has appointed Rick Epstein as CEO. He comes to the new position after serving as CEO of Massachusetts-based OMNIlife science Inc. In his new role, Epstein also will serve on Conventus’ Board of Directors.
"Rick has a track record of accelerating businesses through a focus on customer needs, meaningful product introductions and commercial success," said Richard Mott, Conventus’ board chairman, in a statement. "We are excited to have Rick lead Conventus to its next chapter of growth as we strive to change the practice of medicine."
Epstein has held executive leadership roles within the medical device industry for more than three decades. His career includes stints at Baxter International and Cardinal Health.
He also spent five years with Illinois-based Sonoma Orthopedic Products before becoming CEO of OMNIlife science a year ago.
As CEO of Conventus, Epstein replaces Matt Jewett, who’s listed on LinkedIn as the company’s president and CEO.
Conventus specializes in fracture treatment. One of its main products is the Conventus CAGE, which aims to improve fracture treatment outcomes.
"The Conventus CAGE technology is an innovative platform that is already improving patient outcomes in upper extremity fracture care," said Epstein. “I am excited to join the Conventus team and lead the company through portfolio expansion and commercial growth.”